Are seizures really a problem after the use of antifibrinolytics?

Dmitry Rozin, Madelyn Kahana

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Antifibrinolytic therapy is important in hemostatic control during modern paediatric cardiac and non-cardiac surgery. There continues to be controversy regarding the available agents, e(epsilon)-aminocaproic acid and TXA, to utilize; whether there is a clearly superior choice. This discussion highlights the pharmacology differences between e(epsilon)-aminocaproic acid and TXA and reviews the data comparing the two drugs in paediatric cardiac surgical patients.

Original languageEnglish (US)
Title of host publicationYou're Wrong, I'm Right: Dueling Authors Reexamine Classic Teachings in Anesthesia
PublisherSpringer International Publishing
Pages85-86
Number of pages2
ISBN (Electronic)9783319431697
ISBN (Print)9783319431673
DOIs
Publication statusPublished - Jan 1 2016

    Fingerprint

Keywords

  • ?(epsilon)-aminocaproic acid
  • Antifibrinolytics
  • Neonatal anesthesia
  • Pediatric anesthesia
  • Pediatric cardiac anesthesia
  • Seizures
  • Tranexamic acid (TXA)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rozin, D., & Kahana, M. (2016). Are seizures really a problem after the use of antifibrinolytics? In You're Wrong, I'm Right: Dueling Authors Reexamine Classic Teachings in Anesthesia (pp. 85-86). Springer International Publishing. https://doi.org/10.1007/978-3-319-43169-7_25